Bisoprolol fumarate |
104344-23-2 |
Bisoprolol hemifumarate |
Bisoprolol hemifumarate salt |
Zebeta |
Fondril |
Maintate |
Monocor |
Concor |
Emcor |
Soprol |
(+/-)-Bisoprolol hemifumarate |
NCGC00094255-01 |
(+/-)-Bisoprolol (hemifumarate) |
(E)-but-2-enedioic acid;1-(propan-2-ylamino)-3-4-(2-propan-2-yloxyethoxymethyl)phenoxypropan-2-ol |
TA-4708 |
DSSTox_CID_25794 |
DSSTox_RID_81134 |
DSSTox_GSID_45794 |
2-PROPANOL, 1-4-2-(1-METHYLETHOXY)ETHOXYMETHYLPHENOXY-3-(1-METHYLETHYL)AMINO-, (2E)-2-BUTENEDIOATE (2:1) |
but-2-enedioic acid;1-(propan-2-ylamino)-3-4-(2-propan-2-yloxyethoxymethyl)phenoxypropan-2-ol |
( inverted exclamation markA)-Bisoprolol (hemifumarate) |
CL 297,939 |
Bisobloc |
Bisomerck |
Detensiel |
Emvoncor |
Eurtadal |
Zabesta |
Godal |
Isoten |
Biso-Puren |
CHEBI:3128 |
Concor Plus Forte |
CAS-104344-23-2 |
EMD-33512 |
MFCD00792743 |
EMD-33-512 |
(+-)-1-(p-((2-Isopropoxyethoxy)methyl)phenoxy)-3-isopropylamino-2-propanol hemifumarate |
NCGC00024868-03 |
(+-)-1-((alpha-(2-Isopropoxyethoxy)-p-tolyl)oxy)-3-(isopropylamino)-2-propanol fumarate (2:1) (salt) |
CL-297939 |
Bisoprolol fumarate USAN:USP:JAN |
EMD 33512 |
Zebeta (TN) |
bisoprolol hemi fumarate salt |
SCHEMBL41418 |
Bisoprolol hemifumarate- Bio-X |
CHEMBL1472989 |
DTXSID1045794 |
Bisoprolol fumarate (JP17/USP) |
HMS2096A21 |
HMS3262P04 |
HMS3267A19 |
HMS3411F20 |
HMS3675F20 |
HMS3713A21 |
HY-B0076 |
2C18H31NO4.C4H4O4 |
Tox21_111262 |
Tox21_113409 |
Tox21_500951 |
AKOS015994663 |
Tox21_111262_1 |
CCG-220330 |
CCG-222255 |
CS-1770 |
KS-1033 |
LP00951 |
NSC 759181 |
NCGC00024868-09 |
NCGC00261636-01 |
BB164256 |
D00634 |
344B232 |
A800961 |
SR-01000838106 |
Bisoprolol hemifumarate salt, >=98% (HPLC), solid |
SR-01000838106-2 |
( inverted exclamation markA)-Bisoprolol hemifumarate |
Q27105947 |
Bisoprolol Fumarate 1.0 mg/ml in Methanol (as free base) |
Bisoprolol fumarate, European Pharmacopoeia (EP) Reference Standard |
Bisoprolol fumarate, United States Pharmacopeia (USP) Reference Standard |
Bisoprolol for peak identification, European Pharmacopoeia (EP) Reference Standard |
Bisoprolol for system suitability, European Pharmacopoeia (EP) Reference Standard |
(+/-)-1-4-2-(1-Methylethoxy)ethoxy)methylphenoxy-3-(1-methylethyl)amino-2-propanol hemifumarate |
(AfAEA centa notA inverted exclamation markAfasAA inverted exclamation markAfAEAdaggeratrade markAfA centA centa notA inverted exclamation markAA not)-Bisoprolol (hemifumarate) |
1-(4-((2-isopropoxyethoxy)Methyl)phenoxy)-3-(isopropylaMino)propan-2-ol fuMarate;(+/-)-Bisoprolol Hemifumarate |
2-Propanol, 1-(4-((2-(1-methylethoxy)ethoxy)methyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, (E)-2-butenedioate (2:1) (salt) |